Abstract

Background
Both the Swedish National Patient Register (NPR) and the Swedish Quality Register for inflammatory bowel disease (IBD, SWIBREG) are important sources of research data and information. However, the validity of a diagnosis of IBD in these registers is unknown.
Methods
Medical charts of 129 randomly selected patients from the NPR and 165 patients registered both in SWIBREG and the NPR were reviewed in the main analysis. Patients were classified according to standardized criteria for ulcerative colitis (UC), Crohn's disease (CD), or IBD unclassified (IBD-U). Positive predictive values (PPVs) for CD, UC, IBD-U (only SWIBREG) or having any form of IBD were then calculated.
Results
For cases with ≥2 IBD diagnoses, the PPV in the NPR was 93% (87-97) for any IBD, 79% (66-81) for UC and 72% (60-82) for CD. Restricting the analysis to patients with solely registered diagnoses of UC or CD in the NPR, the PPV increased to 90% (77-97) for UC and 81% (67-91) for CD. Combining data from SWIBREG (≥1 record) and the NPR (≥1 record), the PPV was 99% for any IBD (97-100), 96% (89-99) for for CD.
Conclusion
The validity of the UC, CD and IBD diagnoses is high in the NPR but even higher when cases were identified through SWIBREG and confirmed in the NPR. These results underline the need for a well-functioning Swedish Quality Register for IBD as a complement to the NPR. 
Background and aims
Inflammatory bowel disease (IBD) is an idiopathic disease that consists of chronic gastrointestinal disorders characterized by gastrointestinal inflammation. IBD usually refers to two disease entities: Crohn's disease (CD) and ulcerative colitis (UC). Clinical differentiation between these two types is often challenging, although some disease-specific histologic, endoscopic and radiologic criteria exist. In approximately 20% of the patients' differentiation between CD and UC is not possible at diagnosis; for these cases, the term IBD unclassified (IBD-U) is recommended.
Trend analyses have shown that the incidence of IBD is increasing worldwide. However, the incidence rate varies considerably, with a recorded incidence of UC and CD ranging from 6.3 and 5. ICD-7 in 1964 -1967 , ICD-8 in 1968 -1986 , ICD-9 in 1987 -1996 
Materials and Methods
Study population
All patients with at least one diagnosis of either CD or UC registered in the NPR after 1987
were identified through their ICD coding (see supplementary Table S1 for used ICD codes).
Of these patients, 200 were randomly selected for this study, including patients from all types of hospital (from regional to university hospitals). Another 200 patients were randomly selected from SWIBREG. For each patient, information about the date of the first IBD diagnosis and hospital in which the diagnosis was made was obtained from the National
Board of Health and Welfare. We contacted relevant hospitals and requested medical records that included physician notes, surgery notes, discharge notes, laboratory results, radiology/biopsy/endoscopy referrals and other written referrals for at least 2 years after the first registered diagnosis in the NPR (which could be before 1987). Hospitals failing to provide the medical records within 2 months were sent a reminder and contacted by phone. Figure 1 displays an overview of the selection process of patients eligible for the study.
For the validation of NPR, we excluded 17 individuals with only one registered IBD:
unspecified colitis or proctitis, n=5 (not explicitly assessed as UC or CD by the treating physician); suspected IBD, which was later dismissed, n=2; diverticulosis, n=2; suspected terminal ileitis on computerized tomography (CT), n=2; polyposis, n=1; self-reported IBD in the 1940s with no later symptoms, n=1; anal fissure with no other IBD symptoms, n=1; and resection of terminal ileum believed to be caused by CD, n=1. In addition, two patients were probably misclassified as having CD (ICD code K50.9) but should instead have been registered with C50.9 (breast cancer) and R50.9 ('unspecified fever').
Medical records reviewed n=149
Patients with ≥1 IBD listing in the NPR n=146
Records not received n=51
Excluded* n=3
Patients with ≥2 IBD listings in the NPR included in the analyses n=129
Excluded** n=17
Patients from SWIBREG (n=200)
Medical records reviewed n=168
Included in the analyses n=165
Records not received n=32 Patients from NPR (n=200) Excluded* n=3
Data Elements
Data from the medical charts were abstracted using a standardized form. We retrieved data from pathology, endoscopy and radiology reports, as well as on symptoms and medication at the time of the first registered diagnosis in the NPR. If no information were explicitly recorded for a specific symptom (e.g., abdominal pain) or examination (e.g., endoscopy), the patient was classified as negative for this specific symptom/examination (i.e. 'no abdominal pain' and 'no endoscopy performed'). This method of classifying if a case had undergone an examination or suffered from symptom is likely to underestimate the prevalence of symptoms and procedures but this was considered when setting up the diagnostic criteria by using a probable criteria. From the Swedish National Prescribed Drug Register, additional information about patient dispensation of drugs was retrieved from 2006 and onwards [11] .
The anatomical extent/location of inflammation was assessed using data from endoscopies, barium enemas, CT and magnetic resonance imaging (MRI). All this information was then classified according to the Montreal classification [12] .
Case definition
Cases were classified as definite, probable or negative for UC, CD or IBD-U. Patients fulfilling the Copenhagen criteria were classified as having a definite diagnosis [13, 14] ; patients failing to fulfill the Copenhagen criteria but judged by the treating physician as having IBD with at least two registered IBD diagnoses in the NPR were given a probable diagnosis in line with the treating physician's assessment (UC, CD or IBD-U). If none of these criteria were fulfilled, the patient was classified as negative for IBD. If the medical records were insufficient, i.e. contained too little data to allow assessment, the patient was excluded from the study. The full criteria are presented in Supplementary Table S2 .
Ethical approval
This project was approved by the Stockholm Ethics Review Board (2014/1288-31/4) [Ludvigsson, 2015, PMID 26648756] .
Statistics
Data management was performed using Microsoft Excel and SPSS software 22.0. PPVs were presented with 95% CIs calculated using the Clopper-Pearson method [15] .
Results
In total, 149/200 requested medical records were retrieved to validate the NPR. Three of these charts were excluded because of incompleteness ( Figure 1 ). The main analyses of the NPR included 129 cases (88.4%) with ≥2 recorded IBD diagnoses in the NPR. For the SWIBREG validation, medical records from 168 cases were retrieved, three of which were excluded for incompleteness. The SWIBREG validation was thus based on 165 medical records (Figure 1 ).
Patients in SWIBREG tended to be diagnosed more recently than the average patient in the NPR, which is because registration in SWIBREG started in 2005. This fact could explain the higher retrieval rate for patient charts related to SWIBREG (83.5%) than for the patient charts identified through the NPR (74.5%). Table 1 presents patient characteristics in relation to diagnosis (UC, CD, IBD-U) (n=129).
From the NPR, 120 patients with IBD had either a definite or probable IBD diagnosis (UC n=57, 44%; CD n=53, 41%; IBD-U n=10, 8%). Of the nine patients negative for IBD, six had initially been diagnosed with IBD, but the diagnosis was later dismissed (ischemic colitis n=1, functional gastrointestinal disease n=2, unclassified disease n=3). The remaining three non-IBD cases consisted of one case of miscoding (the patient had heart failure, which has the ICD-10 code I50), one with infectious proctitis and one with infectious enteritis based on positive stool culture.
Of the cases validated from SWIBREG, 81 (49%) had UC, 79 (48%) CD and 4 (2%) IBD-U.
One patient did not fulfill the diagnostic criteria for IBD. This patient had a negative histopathology report and an ileocolonoscopy without any macroscopic signs of inflammation.
For patients in the NPR who met the criteria for UC, diarrhea (79%) and bloody stool (70%)
were the most frequent symptoms (Table 1) . These symptoms were also most frequent in UC in SWIBREG: diarrhea 83% and bloody stool 74% (Table 1) . Among patients in the NPR who met the criteria for CD, abdominal pain and diarrhea were the most prevalent symptoms; the same pattern was evident for patients with CD in SWIBREG ( The extent of inflammation was similar in UC patients from the NPR and SWIBREG. In total, 11% of 1 the NPR cases fulfilling UC criteria had ulcerative proctitis (E1), 30% left-sided colitis (E2) and 44% 2 extensive colitis (E3). Patient chart data did not allow us to classify the extent of inflammation in the 3 remaining 16% (Table 2) . Corresponding figures for the SWIBREG cohort were 10%, 26%, 48%, 4 respectively (impossible to define extent: 16% also here). Similarly, of the CD patients in the NPR, 5 40% had ileal disease (L1), 23% colonic disease (L2) and 15% ileocolonic disease (L3) (no data on 6 location in 23%). Coexisting upper gastrointestinal (GI) disease (L4) was present in 0%, 25% and 7 13% of the cases with ileal, colonic and ileocolonic disease, respectively ( Table 2 ). The 8 corresponding figures for SWIBREG cases were 37%, 26% and 24%, respectively (no data on 9 location in 23%). Coexisting upper GI disease (L4) was present in 7%, 10% and 0% of the cases, 10 respectively. 11 12 13 (Table 3) . In-or outpatient status at first registered diagnosis in the NPR did not substantially change 21 the PPV for the respective diagnosis (Table 3) . Limiting the analysis to cases from NPR with a solely 22 registered diagnosis of UC (n=41) or CD (n=48) resulted in increased PPVs of 90% (77-97) for UC 23 and 81% (67-91) for CD. For an overview of the PPVs, see Table 3 . 24 25 26 27 
28
For cases registered as UC or CD in the NPR, only 8 and 6%, respectively, were classified as negative 29 for IBD; instead, most misclassifications were due to individuals first being diagnosed with UC or CD 30 but later declared to have another type of IBD (see Table 4 for data on re-classifications). 31
Corresponding figures for SWIBREG were 0%, 1% and 0% for UC, CD and IBD-U, respectively. 32 
Sub-analysis 39
When including all cases (N=146) randomly selected from the NPR (≥1 registered diagnosis), 75% 40 (95% CI: 64-85) met the UC criteria and 68% (95% CI: 56-78) the CD criteria (see Supplementary 41 Table S3 ). 42
43
Restricting the analyses of SWIBREG to cases with congruent diagnoses in SWIBREG and the first 44 diagnosis in NPR (N=143) showed that 99% (95% CI: 92-100) and 95% (95% CI: 87-98) met the 45 criteria for UC and CD, respectively (see Supplementary Table S4) . 46 47 
Discussion
48
This study aimed to validate IBD, and specifically, UC and CD in the NPR and SWIBREG. 49
Our main finding is the high validity of the UC and CD diagnoses in the NPR, especially for 50 any IBD, as most misclassified cases of UC and CD were made up of the other IBD diagnosis 51 or IBD-U. For ≥2 IBD diagnoses in the NPR, the PPV for any IBD was 93%. The validity 52 was even higher for patients identified through SWIBREG and confirmed by ≥1 NPR 53 diagnosis: 99% for IBD, 96% for UC and 90% for CD. 54
55
The results of our validation study should be compared with those of Ekbom et al. in 1991, 56 who studied IBD registered diagnoses in the NPR from Uppsala County, Sweden in 1965-57
1983. That study reported a PPV of 74% for IBD. However, for several reasons, we expected 58 the PPV for IBD in our study to be higher. First, we included cases with at least two NPR 59 diagnoses of IBD, whereas Ekbom et al. included patients with at least one IBD diagnosis 60 from the NPR, but also included patients with possible IBD (e.g., patients with a diverticulitis 61 diagnosis in the NPR, as such patients may represent misclassified IBD). Considering that our 62 study used more stringent inclusion criteria, a higher PPV would be expected. Restricting the 63 analysis to cases with a UC diagnosis (and never a CD diagnosis) or a CD diagnosis (and 64 never a UC diagnosis) in the NPR, the PPVs increased to 90% for UC and 81% for CD. It 65 seems that out-or inpatient status at first diagnosis does not affect PPV more than marginally 66 (Table 3) . However, because of the small number of cases that had their first diagnoses 67 recorded as outpatients (n=17), no firm conclusions can be drawn as to the importance of out-68 or inpatient status at first IBD diagnosis. 69
70
The PPV for IBD in our study is in line with the 85-95% reported for other diagnoses in the 71 NPR, and with the highest PPVs generally seen for severe diseases [7] . Earlier validation has 72 reported PPVs close to 90% for other inflammatory diseases (e.g., rheumatoid arthritis, 90% 73 and ankylosing spondylitis, 89%) [16, 17] with better access to patient chart data. When a more stringent criterion was applied to 82 identify cases from SWIBREG (only those with a congruent first diagnosis in NPR and 83 diagnosis in SWIBREG), specificity increased as predicted for both UC (PPV=99%, 95% CI: 84 92-100) and CD (PPV=95%, 95% CI; 87-98) (Supplementary Table S4) . 85
86
Our study shows a higher PPV for diagnoses of UC or CD registered in SWIBREG and 87 confirmed by ≥1 NPR record than for cases with ≥2 records of IBD in the NPR. Several 88 explanations may account for this finding. The diagnoses in the NPR are recorded at the first 89 visit with suspected IBD: sometimes the initial diagnosis is incorrect (e.g., initially classified 90 as UC but later re-classified as CD), which lowers the calculated PPV. This argument is 91 supported by the substantially higher PPV for any IBD than for UC or CD separately (Table  92 3). In contrast, subjects from SWIBREG are not included in this register (SWIBREG) until 93 the treating physician is certain about the diagnosis (IBD or not) and which type of IBD is 94 present (UC, CD or IBD-U). Moreover, as mentioned above cases are exclusively diagnosed 95 by a specialist or a resident in internal medicine or gastroenterology. Taken together, these 96 factors should lead to a higher PPV for diagnoses in SWIBREG than in the NPR. 97 98 This study also examined symptoms and signs in IBD. In patients with UC diarrhea (79/83%: 99 NPR/SWIBREG cohort) and hematochezia (70/74%) were the most common symptoms. 100
Abdominal pain (70/71%) and diarrhea (68/65%) were the most common symptoms in CD. 101
These data are consistent with international data that have shown that hematochezia and 102 diarrhea are the most common symptoms in UC [18] . For CD, diarrhea is the most common 103 symptom and abdominal pain is present in about 70% of the cases before diagnosis [19] . 104 105 Finally, disease extent and location of disease were examined. In UC, the inflammation was 106 mostly an extensive colitis (44/48%: NPR/SWIBREG cohort) followed by left-sided colitis 107 (30/26%). In CD, inflammation mostly involved the terminal ileum (53/58%). International 108 data have shown that the inflammation for UC at time of diagnosis is located most often in the 109 rectum or sigmoid colon (30-50%), followed by left-sided-colitis (20-30%) and pancolitis 110 (20%) [20] . The more extensive inflammation for UC in our material than in the literature 111 could be explained by progression of inflammation since our data is from the time of first 112 registration in the NPR, which in some cases could be after the time of initial diagnosis. 113
114
Our study has several strengths. First, the random selection from the NPR and SWIBREG and 115 the nationwide approach support the contention that the results are likely representative of 116 expected results nationally. Second, we requested charts from a broad timespan (at least 2 117 years), a strategy that increases the possibility of including relevant diagnostic examinations 118 and medication. 119 120 Some limitations should be acknowledged. First, we were not always able to retrieve 121 complete medical records (e.g., we identified histopathology referrals in about 75% of the 122 patients and colonoscopy referrals in 65%, although most, if not all, the patients are likely to 123 have undergone these procedures). To address the possible lack of data we used a probable 124 criterion for IBD, which was based on the assessment of the treating physicians (who likely 125 had read the referrals) after their investigation. Second, we did not retrieve all of the requested 126 charts (51/200 for the NPR and 32/200 for SWIBREG were missing). We cannot exclude that 127 missing charts have biased our results somewhat. We tried to minimize the risk of bias by re-128 requesting charts first by letter and then by telephone to those hospitals and clinics that had 129 not responded. Third, we did not include patients with other forms of IBD, such as 130 collagenous and lymphocytic colitis, but these constitute only a small percentage of the total 131 number of IBD cases. 132
133
Conclusions
134
In conclusion, the validity of a diagnosis of UC, CD and IBD is high in the NPR but even 135 higher when cases were identified through SWIBREG and confirmed in the NPR. 
